[go: up one dir, main page]

AU4031897A - Stanozolol-containing percutaneously absorbable preparation - Google Patents

Stanozolol-containing percutaneously absorbable preparation

Info

Publication number
AU4031897A
AU4031897A AU40318/97A AU4031897A AU4031897A AU 4031897 A AU4031897 A AU 4031897A AU 40318/97 A AU40318/97 A AU 40318/97A AU 4031897 A AU4031897 A AU 4031897A AU 4031897 A AU4031897 A AU 4031897A
Authority
AU
Australia
Prior art keywords
stanozolol
absorbable preparation
percutaneously absorbable
containing percutaneously
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40318/97A
Inventor
Hiroshi Kuroda
Tsutomu Nekama
Takeshi Wakiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP22849496A external-priority patent/JPH1072353A/en
Priority claimed from JP22849396A external-priority patent/JPH1072354A/en
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Publication of AU4031897A publication Critical patent/AU4031897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40318/97A 1996-08-29 1997-08-29 Stanozolol-containing percutaneously absorbable preparation Abandoned AU4031897A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP22849496A JPH1072353A (en) 1996-08-29 1996-08-29 Stanozolol-containing transdermal patch
JP22849396A JPH1072354A (en) 1996-08-29 1996-08-29 Stanozolol-containing transdermal preparations
JP8-228494 1996-08-29
JP8-228493 1996-08-29
PCT/JP1997/003014 WO1998008547A1 (en) 1996-08-29 1997-08-29 Stanozolol-containing percutaneously absorbable preparation

Publications (1)

Publication Number Publication Date
AU4031897A true AU4031897A (en) 1998-03-19

Family

ID=26528283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40318/97A Abandoned AU4031897A (en) 1996-08-29 1997-08-29 Stanozolol-containing percutaneously absorbable preparation

Country Status (2)

Country Link
AU (1) AU4031897A (en)
WO (1) WO1998008547A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
GB2421183A (en) * 2004-12-17 2006-06-21 Stegram Pharmaceuticals Ltd Topical formulations for use in the treatment or prevention of skin cancers
US9610296B2 (en) * 2013-01-21 2017-04-04 Edward M. Lichten Inducing lactation in nursing females

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676327B2 (en) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 Steroid ointment formulation
JP2638635B2 (en) * 1989-01-31 1997-08-06 積水化学工業株式会社 Transdermal formulation

Also Published As

Publication number Publication date
WO1998008547A1 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
AU692944B2 (en) Percutaneously absorbable patch
AU1281895A (en) Percutaneously absorbable preparation
AU4594197A (en) Suture cutter
AU2330097A (en) Improved trocar
AU4553897A (en) Remineralising composition
AU3387997A (en) Autonotification
AUPO152596A0 (en) Roofbolter
AU2684197A (en) Handleset
AU5865694A (en) Novel, percutaneously absorbable preparation
AU692924B2 (en) Percutaneously absorbable preparation
EP0719561A4 (en) Percutaneously absorbable preparation
AU681566B3 (en) Knife
AU2090897A (en) Hydroxyhexahydropyridazines
AU3620297A (en) Substituted triazoloazinesulphonamides
AU3130597A (en) Tristetraprolin
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU2237197A (en) Fishing-lure
AU4604397A (en) (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines
AU1900097A (en) Cremators
AU4031897A (en) Stanozolol-containing percutaneously absorbable preparation
AU1597197A (en) Thienoquinolines
AU3557397A (en) Double-tau-profile
AU1681799A (en) Percutaneously absorbable levodopa-containing preparation
AU5482698A (en) Longlines